Bipolar Disorder
Conference Coverage
Depression: Think outside of the box for diagnosis, treatment
Patients typically don’t fit into “convenient (DSM-5) buckets.” Consider likely comorbidities.
Commentary
Lithium toxicity: Lessons learned
Lithium carbonate is a mood stabilizer.
Evidence-Based Reviews
Managing excited catatonia: A suggested approach
Our algorithm can facilitate identification and treatment of this challenging syndrome.
From the Journals
Behavioral treatment tied to lower medical, pharmacy costs
Diagnosis of a behavioral health condition is often delayed, and most affected individuals receive little to no treatment.
From the Journals
Clinical factors drive hospitalization after self-harm
Identifying subgroups of suicidal patients in the ED might help refine treatment and prevention.
Med/Psych Update
Lithium-associated hypercalcemia: Monitoring and management
Regular monitoring of calcium levels in patients receiving lithium can improve outcomes.
Opinion
Long-term behavioral follow-up of children exposed to mood stabilizers and antidepressants: A look forward
Both antidepressants and newer mood stabilizers have been shown to be safe in pregnancy.
From the Journals
Machine learning identifies childhood characteristics that predict bipolar disorder
With further development, the model could be used to identify at-risk children via electronic medical records, enabling earlier monitoring and...
Commentary
Lamotrigine for bipolar depression?
In reading Dr. Nasrallah's August 2022 editorial (“Reversing depression: A plethora of therapeutic strategies and mechanisms,” Current Psychiatry...
Conference Coverage
Bipolar risk and parental age: What’s the relationship?
“We must stress that this risk is moderate, and it must be kept in perspective,” said Dr. Giovanna Fico.
From the Journals
‘Disturbing’ lack of follow-up care after psychiatric crises
Patients who had received both primary care and mental health care before an acute event had the highest odds of receiving follow-up.